Key Takeaways The Biden administration proposed a new policy Tuesday that would allow Medicare and Medicaid to cover ...

The Biden administration is looking to expand access to anti-obesity GLP-1 drugs like Ozempic and Wegovy for people who have ...

If the proposal is finalized, it could set the stage for a showdown between the pharmaceutical industry and the Trump ...

Though some doctors have been trying to classify “obesity” as a “chronic illness,” being fat and being ill aren’t the same ...

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

Washington — Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic ...

Dr. Oz has extolled Ozempic’s promise for weight-loss. Now Medicare, which Trump wants Oz to oversee, may cover it.

A doctor, bariatric surgeon and professor say that treatments other than weight-loss drugs are needed to fix the obesity ...

Medicare and Medicaid would cover weight-loss drugs like Wegovy and Ozempic under a new rule proposed by President Joe Biden on Tuesday, increasing access to the widely popular medications to ...

Donald Trump's top pick to lead Medicare, celebrity doctor Mehmet Oz, has a glaring conflict of interest: that he was ...

The drugs include Novo Nordisk’s Wegovy and Ozempic as well as Eli Lilly’s Zepbound and Mounjaro ... Private health insurers ...

Washington — Millions of Americans with obesity would be eligible to have popular drugs used for weight loss like Wegovy or Ozempic covered by Medicare and Medicaid under a new rule the Biden ...